
Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
BLCO · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthBausch + Lomb Corporation carries a net debt position of $4.99B. Total debt ($5.37B) exceeds cash on hand ($383.0M). Bausch + Lomb Corporation cash vs debt ratio: 7% cash / 93% debt.
Cash on hand history
Annual cash on hand by year
BLCO cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Bausch + Lomb Corporation (BLCO) cash on hand as of December 31, 2025 is $383.0M, comprising $383.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Bausch + Lomb Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bausch + Lomb Corporation cash reserves or cash position.
Bausch + Lomb Corporation annual cash on hand history shows increased +25.6% in 2025: increased +25.6% in 2025. Bausch + Lomb Corporation cash reserves in 2025 reflect the company's capital allocation strategy.
Bausch + Lomb Corporation carries total debt of $5.37B against cash of $383.0M, resulting in a net debt position of -$4.99B. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
BLCO cash on hand · 5 questionsAs of December 31, 2025, Bausch + Lomb Corporation (BLCO) has $383,000,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $383,000,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $268,000,000. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Bausch + Lomb Corporation · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025